mRNA-1273 Noninferior To BNT162b2 After Third COVID-19 Vaccine Dose In Immunosuppressed Patients, Research Suggests
April 20, 2023
Infectious Disease Advisor (4/19, Davis) reports that results of an extension of a randomized controlled trial suggest “noninferiority between mRNA-1273 and BNT162b2 vaccination among patients with varying levels of immunosuppression following receipt of...